U.S. Markets closed

Assembly Biosciences: 3Q Earnings Snapshot

CARMEL, Ind. (AP) _ Assembly Biosciences Inc. (ASMB) on Thursday reported a loss of $25 million in its third quarter.

The Carmel, Indiana-based company said it had a loss of 96 cents per share.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 93 cents per share.

The biotech drug developer posted revenue of $4.2 million in the period, topping Street forecasts. Four analysts surveyed by Zacks expected $3.4 million.

Assembly Biosciences shares have dropped 28% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $16.22, a drop of 29% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ASMB at https://www.zacks.com/ap/ASMB